Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis.
作者:
主题词
人类(Humans);多发性硬化(Multiple Sclerosis);脑白质病, 进行性多灶性(Leukoencephalopathy, Progressive Multifocal);脑(Brain);中枢神经系统疾病(Central Nervous System Diseases);磁共振成像(Magnetic Resonance Imaging);萎缩(Atrophy);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);免疫因子类(Immunologic Factors)
DOI
10.1177/13524585231225855
PMID
38235514
发布时间
2024-02-10
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文